GSO ISO 11978:2024
ISO 11978:2017
Gulf Standard
Current Edition
·
Approved on
25 April 2024
Ophthalmic optics — Contact lenses and contact lens care products — Labelling
GSO ISO 11978:2024 Files
English
7 Pages
Current Edition
Reference Language
Obtaining this standard through the store is currently unavailable.
You can acquire it directly from its source or from one of the member countries stores
GSO ISO 11978:2024 Scope
ISO 11978:2017 specifies the information to be provided by the manufacturer of contact lenses and contact lens care products to ensure the correct and safe use of these devices and their accessories by both types of user of contact lenses: the eye care professional and the contact lens wearer.
ISO 11978:2017 does not specify the format in which such information shall be provided.
Best Sellers From Health Sector
GSO 2017:2023
Gulf Standard
Personal Care and Baby Wet Wipes

GSO 2241:2023
Gulf Standard
Cosmetic Products - Body Cleaners

GSO 2063:2023
Gulf Standard
Cosmetic Products - Hair Conditioner (Balsam)

GSO 1223:2023
Gulf Standard
Cosmetic Products-Deodorants

Recently Published from Health Sector
GSO ISO 20776-2:2024
ISO 20776-2:2021
Gulf Standard
Clinical laboratory testing and in vitro diagnostic test systems
— Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices
— Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution


GSO ISO 27186:2024
ISO 27186:2020
Gulf Standard
Active implantable medical devices — Four-pole connector system for implantable cardiac rhythm management devices — Dimensional and test requirements


GSO ISO 28620:2024
ISO 28620:2020
Gulf Standard
Medical devices
— Non-electrically driven portable infusion devices


GSO ISO 20776-1:2024
ISO 20776-1:2019
Gulf Standard
Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices
— Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases

